Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;29(6):1004-1012.
doi: 10.5603/CJ.a2020.0129. Epub 2020 Oct 1.

Baroreflex sensitivity but not microvolt T-wave alternans can predict major adverse cardiac events in ischemic heart failure

Affiliations

Baroreflex sensitivity but not microvolt T-wave alternans can predict major adverse cardiac events in ischemic heart failure

Damian K Kaufmann et al. Cardiol J. 2022.

Abstract

Background: Major adverse cardiovascular events (MACE) constitutes the main cause of morbidity and mortality in ischemic heart failure (HF) patients. The prognostic value of the autonomic nervous system parameters and microvolt T-wave alternans (MTWA) in this issue has not been identified to date. The aim herein, was to assess the usefulness of the abovementioned parameters in the prediction of MACE in HF patients with left ventricular systolic dysfunction of ischemic origin.

Methods: Baroreflex sensitivity (BRS), heart rate variability (HRV), MTWA and other well-known clinical parameters were analyzed in 188 ischemic HF outpatients with left ventricular ejection fraction (LVEF) ≤ 50%. During 34 (14-71) months of follow-up, 56 (30%) endpoints were noted.

Results: Univariate Cox analyses revealed BRS (but not HRV), MTWA, age, New York Heart Association functional class III, LVEF, implantable cardioverter-defibrillator presence, use of diuretics and antiarrhythmic drugs, diabetes, and kidney insufficiency were defined as significant predictors of MACE. Pre-specified cut-off values for MACE occurrence for the aforementioned continuous parameters (age, LVEF, and BRS) were: ≥ 72 years, ≤ 33%, and ≤ 3 ms/mmHg, respectively. In a multivariate Cox analysis only BRS (HR 2.97, 95% CI 1.35-6.36, p < 0.006), and LVEF (HR 1.98, 95% CI 0.61-4.52, p < 0.038) maintained statistical significance in the prediction of MACE.

Conclusions: Baroreflex sensitivity and LVEF are independent of other well-known clinical parameters in the prediction of MACE in patients with HF of ischemic origin and LVEF up to 50%. BRS ≤ 3 ms/mmHg and LVEF ≤ 33% identified individuals with the highest probability of MACE during the follow-up period.

Keywords: autonomic nervous system; baroreflex sensitivity; heart failure; heart rate variability; ischemic cardiomyopathy; left ventricular dysfunction; microvolt T-wave alternans.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

Figures

Figure 1
Figure 1
Kaplan-Meier curves illustrating the probability of major adverse cardiovascular events (MACE) during the follow-up period according to the cut-off value for baroreflex sensitivity (BRS).
Figure 2
Figure 2
Kaplan-Meier curves illustrating the probability of major adverse cardiovascular events (MACE) during the follow-up period according to the cut-off value for left ventricular ejection fraction (LVEF).
Figure 3
Figure 3
Kaplan-Meier curves illustrating the probability of major adverse cardiovascular events (MACE) during the follow-up period according to the combined parameter (left ventricular ejection fraction [LVEF] + baroreflex sensitivity [BRS]).

Similar articles

References

    1. Lavoie L, Khoury H, Welner S, et al. Burden and prevention of adverse cardiac events in patients with concomitant chronic heart failure and coronary artery disease: a literature review. Cardiovasc Ther. 2016;34(3):152–160. doi: 10.1111/1755-5922.12180. - DOI - PMC - PubMed
    1. Verrier RL, Klingenheben T, Malik M, et al. Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology. J Am Coll Cardiol. 2011;58(13):1309–1324. doi: 10.1016/j.jacc.2011.06.029. - DOI - PMC - PubMed
    1. Rovere M, Bigger J, Marcus F, et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet. 1998;351(9101):478–484. doi: 10.1016/s0140-6736(97)11144-8. - DOI - PubMed
    1. La Rovere MT, Maestri R, Robbi E, et al. Comparison of the prognostic values of invasive and noninvasive assessments of baroreflex sensitivity in heart failure. J Hypertens. 2011;29(8):1546–1552. doi: 10.1097/HJH.0b013e3283487827. - DOI - PubMed
    1. Kleiger RE, Stein PK, Bigger JT. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol. 2005;10(1):88–101. doi: 10.1111/j.1542-474X.2005.10101.x. - DOI - PMC - PubMed
-